MEDA Pharma GmbH & Co. KG

Pancreatic Exocrine Insufficiency after Pancreatic Surgery

Research activity includes adults living with pancreatic exocrine insufficiency following total pancreatectomy, with attention to the ongoing need for pancreatic enzyme replacement therapy in post-surgical care.

  • Post-pancreatectomy digestive support
  • Pancreatic enzyme replacement therapy
  • Exocrine pancreatic function

The therapeutic focus extends to managing malabsorption-related symptoms and supporting nutritional intake in patients with loss of pancreatic enzyme production.

Cystic Fibrosis and Digestive Enzyme Deficiency

Clinical research also involves patients with cystic fibrosis who experience pancreatic exocrine insufficiency, reflecting interest in the gastrointestinal and nutritional burden associated with the disease.

  • CF-related pancreatic insufficiency
  • Gastrointestinal symptom control
  • Nutritional management

These studies are centered on the practical use of enzyme-based treatment in a chronic inherited disorder with significant digestive involvement.

Pancreatic Enzyme Replacement Therapy

The sponsor’s research landscape is closely tied to pancreatic enzyme replacement therapy, with interest in treatment acceptability and the role of enzyme supplementation in daily meal-related care.

  • Enzyme supplementation
  • Meal-related treatment use
  • Patient acceptability

This area reflects a therapeutic emphasis on improving the usability of enzyme therapy for patients who depend on it for digestion and nutrient absorption.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Pancreatic Enzyme Replacement Therapy for Adults with Pancreatic Exocrine Insufficiency After Pancreatic Surgery

    Recruiting

    3 1 1 1
    Investigated drugs:
    Germany Poland Spain
  • Study on the Acceptability of Pancreas Powder for Patients with Cystic Fibrosis and Pancreatic Exocrine Insufficiency

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Germany